{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:23:54Z","timestamp":1783092234809,"version":"3.54.6"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM107146"],"award-info":[{"award-number":["R01GM107146"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejps.2026.107550","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:30:21Z","timestamp":1778283021000},"page":"107550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cocrystal mitigates the effects of elevated gastric pH on oral absorption of weakly basic drugs: a case study with ketoconazole-succinic acid cocrystal on beagle dogs"],"prefix":"10.1016","volume":"222","author":[{"given":"Yitian Marguerite","family":"Tucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-7152","authenticated-orcid":false,"given":"Tatiane Cogo","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-1986","authenticated-orcid":false,"given":"Na\u00edr","family":"Rodr\u00edguez-Hornedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107550_bib0001","doi-asserted-by":"crossref","DOI":"10.1007\/s11705-017-1658-7","article-title":"Oral product input to the GI tract: GIS an oral product performance technology","author":"Amidon","year":"2017","journal-title":"Front. Chem. Sci. Eng."},{"key":"10.1016\/j.ejps.2026.107550_bib0002","series-title":"Avdeef, Alex. Absorption and Drug Development: Solubility, Permeability and Charge State","article-title":"pKa determination","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.ejps.2026.107550_bib0003","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpb.2012.07.009","article-title":"Drug precipitation-permeation interplay: Supersaturation in an absorptive environment","volume":"82","author":"Bevernage","year":"2012","journal-title":"Euro. J. Pharma. Biopharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.xphs.2018.09.028","article-title":"Mechanistic Analysis of Cocrystal Dissolution, Surface pH, and Dissolution Advantage as a Guide for Rational Selection","volume":"108","author":"Cao","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107550_bib0005","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/acs.cgd.7b01206","article-title":"Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug","volume":"18","author":"Chen","year":"2018","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107550_bib0006","series-title":"Cocrystals Mitigate the Effect of pH on Solubility and Dissolution of Basic Drugs (PhD Thesis)","author":"Chen","year":"2017"},{"key":"10.1016\/j.ejps.2026.107550_bib0007","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/AAC.39.8.1671","article-title":"Effects of an Acidic Beverage (Coca-Cola) on Absorption of Ketoconazole","volume":"39","author":"Chin","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107550_bib0008","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1023\/A:1015827908309","article-title":"Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107550_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/S0928-0987(00)00181-0","article-title":"In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs","author":"Dressman","year":"2000","journal-title":"Euro. J. Pharma. Sci."},{"key":"10.1016\/j.ejps.2026.107550_bib0010","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/jps.22486","article-title":"Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds","volume":"100","author":"Fancher","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107550_bib0011","doi-asserted-by":"crossref","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting In vivo performance of class I and II drugs","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107550_bib0012","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/cg901232h","article-title":"Cocrystal eutectic constants and prediction of solubility behavior","volume":"10","author":"Good","year":"2010","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107550_bib0013","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/cg801039j","article-title":"Solubility advantage of pharmaceutical cocrystals","volume":"9","author":"Good","year":"2009","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107550_bib0014","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejpb.2023.06.002","article-title":"The effects of degree and duration of supersaturation on in vivo absorption profiles for highly permeable drugs, dipyridamole and ketoconazole","volume":"189","author":"Higashino","year":"2023","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2026.107550_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1211\/0022357022511","article-title":"Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine","volume":"56","author":"Kostewicz","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107550_bib0016","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejpb.2019.01.026","article-title":"Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule","volume":"136","author":"Koziolek","year":"2019","journal-title":"Euro. J. Pharma. Biopharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0017","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1039\/C6CC00898D","article-title":"How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability","volume":"52","author":"Kuminek","year":"2016","journal-title":"Chem. Comm."},{"key":"10.1016\/j.ejps.2026.107550_bib0018","series-title":"Multi-Component Crystals","first-page":"205","article-title":"Solution co-crystallisation and its applications","author":"Leyssens","year":"2018"},{"key":"10.1016\/j.ejps.2026.107550_bib0019","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/cg400638g","article-title":"Ketoconazole salt and co-crystals with enhanced aqueous solubility","volume":"13","author":"Martin","year":"2013","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2026.107550_bib0020","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/mp400426f","article-title":"Assessing the risk of pH-dependent absorption for new molecular entities: A novel in vitro dissolution test, physicochemical analysis, and risk assessment strategy","volume":"10","author":"Mathias","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0021","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1021\/mp200062a","article-title":"Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effect","volume":"8","author":"Mitra","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0022","doi-asserted-by":"crossref","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in vitro testing","author":"Mudie","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/bdd.546","article-title":"In vitro and in vivo comparative study of intraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion","volume":"28","author":"Park","year":"2007","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2026.107550_bib0024","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.xphs.2018.10.051","article-title":"Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs","volume":"108","author":"Patel","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107550_bib0025","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/AAC.35.9.1765","article-title":"Effects of Ranitidine and Sucralfate on Ketoconazole Bioavailability","volume":"35","author":"Piscitelli","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107550_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118862","article-title":"Comparison of induction methods for supersaturation: pH shift versus solvent shift","volume":"573","author":"Plum","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0027","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/mp050099m","article-title":"Reaction crystallization of pharmaceutical molecular complexes","volume":"3","author":"Rodr\u00edguez-Hornedo","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0028","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejps.2016.12.017","article-title":"Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling","volume":"100","author":"Ruff","year":"2017","journal-title":"Euro. J. Pharma. Sci."},{"key":"10.1016\/j.ejps.2026.107550_bib0029","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1018918316253","article-title":"pH-Related Changes in the Absorption of Dipyridamole in the Eldery","volume":"11","author":"Russell","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.ejps.2026.107550_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2026.114986","article-title":"Enhancing bioavailability of a weakly basic drug through cocrystallization: PBPK modeling of ketoconazole\u2013succinic acid","volume":"220","author":"Santos Goes","year":"2026","journal-title":"Euro. J. Pharma. Biopharm."},{"key":"10.1016\/j.ejps.2026.107550_bib0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(00)00200-5","article-title":"pH-independent release of a weakly basic drug from water-insoluble and-soluble matrix tablets","volume":"67","author":"Streubel","year":"2000","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejps.2026.107550_bib0032","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11095-006-0162-4","article-title":"Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test","volume":"23","author":"Takano","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107550_bib0033","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejps.2017.02.042","article-title":"The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS)","volume":"102","author":"Tsume","year":"2017","journal-title":"Euro. J. Pharma. Sci."},{"key":"10.1016\/j.ejps.2026.107550_bib0034","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jac\/6.4.552","article-title":"Influence of gastric acidity on the bioavailability of ketoconazole","volume":"6","author":"Van der Meer","year":"1980","journal-title":"J. Antimicro."},{"key":"10.1016\/j.ejps.2026.107550_bib0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11095-004-1185-3","article-title":"pH-Dependent dissolution in Vitro and absorption in Vivo of weakly basic drugs: Development of a canine model","volume":"22","author":"Zhou","year":"2005","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:13:34Z","timestamp":1783091614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"alternative-id":["S0928098726001247"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107550","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cocrystal mitigates the effects of elevated gastric pH on oral absorption of weakly basic drugs: a case study with ketoconazole-succinic acid cocrystal on beagle dogs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107550"}}